Status:
COMPLETED
Use of an External Erectile Device in Transgender Man Following Phalloplasty
Lead Sponsor:
Boston Children's Hospital
Conditions:
Transsexualism
Surgery
Eligibility:
All Genders
18-64 years
Phase:
NA
Brief Summary
The purpose of this study is to test whether an external erectile prosthesis (The Elator™) is a feasible alternative to internal erectile prostheses for transgender men who have undergone a phalloplas...
Detailed Description
There are approximately 1.4 million transgender adults in the United States. Approximately half are transgender men, individuals who have a male gender identity but were assigned female at birth. A na...
Eligibility Criteria
Inclusion
- Primary study subject must have had a phalloplasty with glansplasty a minimum of 1 year before enrollment and must have protective sensation to the tip of the phallus
- Primary study subject must be in a relationship in which they are having, or would like to have, penetrative sex with their partner. Partner must also be interested in having penetrative sex with primary subject.
- Both primary study subject and partner must have (individual) e-mail addresses and access to the Internet to complete surveys
- Primary study subject must be willing to be contacted by postal mail, in order to receive the device
- Both subjects must be willing to receive e-mails
Exclusion
- Either subject or partner does not speak English
- Primary subject has an internal erectile prosthesis.
Key Trial Info
Start Date :
July 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2022
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT03823014
Start Date
July 1 2019
End Date
July 1 2022
Last Update
July 21 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Participation in this study is from participants home.
Boston, Massachusetts, United States, 02115